XCUR
EXICURE, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.25
−7.41%Sep 16, 2026, 12:00 UTC
Nasdaq granted Exicure, Inc. an extension through December 2, 2026 to regain compliance with Nasdaq Listing Rule 5550(b)(1) regarding stockholders' equity.
Source:Aug 3, 2026, 13:24 UTC
Exicure announced it will issue 172,058 shares of common stock to GPCR Therapeutics in August 2026 to settle a $1.0 million clinical milestone payment obligation under their License and Collaboration Agreement.
Source:Jun 30, 2026, 12:40 UTC
Exicure, Inc. announced changes to its Board of Directors and Board committees following actions approved at a special meeting on June 24, 2026.
Source:Jun 10, 2026, 20:01 UTC
Exicure received a Nasdaq notice for non-compliance with minimum stockholders' equity requirement.
Source:Jun 1, 2026, 20:00 UTC
Exicure received a Nasdaq delinquency notice for delayed Form 10-Q filing and subsequently filed the Form 10-Q on May 29, 2026.
Source: